Skip to content

Don’t be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review

Corinna L. Felsch, Kim P. C. Kuypers

Neuroscience & Biobehavioral Reviews June 6, 2022 DOI: 10.1016/j.neubiorev.2022.104724 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Topics Anxiety Meditation Psilocybin
Keywords Psychological intervention Psychotherapist Social anxiety Clinical psychology Intervention counseling Cognitive behavioral therapy Hallucinogen
Citations 23
Key findings Psilocybin-assisted meditation interventions might change cognitive processes linked to SAD by modulating salience network connectivity, balancing cortical-midline structures, and increasing frontoparietal control over amygdala reactivity.

Abstract

Background: Current first-line treatment for social anxiety disorder (SAD), one of the most prevalent anxiety disorders, is limited in its efficacy. Hence, novel treatment approaches are urgently needed. The current review suggests a combination of meditation-based interventions and the administration of a psychedelic as a future alternative treatment approach. While both separate treatments show promise in the treatment of (other) clinical conditions, their combination has not yet been investigated in the treatment of psychopathologies.

Aim: With a systematic literature review, we aim to identify the potential mechanisms by which combined psilocybin and mindfulness treatment could adjust anomalous neural activity underlying SAD and exert therapeutic effects.

Results: Thirty experimental studies investigating the neural effects of meditation or psilocybin treatment in healthy and patient samples were included. Findings suggest that psilocybin-assisted meditation interventions might change cognitive processes like biased attention to threat linked to SAD by modulating connectivity of the salience network, balancing the activity and connectivity of cortical-midline structures, and increasing frontoparietal control over amygdala reactivity.

Conclusions: Future studies should investigate whether psilocybin-assisted mindfulness-based intervention can provide therapeutic benefits to SAD patients who are do not remit following conventional therapy.

Comparable studies

Other systematic reviews and meta-analyses on psilocybin, most cited first.

Study Year Design Participants
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188
Blinding and expectancy confounds in psychedelic randomized controlled trials 2021 Systematic review
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Patients from included clinical trials 2016 Systematic review
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis People with elevated symptoms of anxiety and depression 2020 Meta-analysis n = 117
Default Mode Network Modulation by Psychedelics: A Systematic Review Participants from included studies 2022 Systematic review

Explore topics

By condition and practice